01 Shift Toward Patient-Friendly and Self-Collection Technologies The capillary blood collection devices market is shifting toward patient-friendly technologies that reduce reliance on conventional needle-based venipuncture. Newer devices use upper-arm collection, vacuum assistance, microfluidics, and simplified activation mechanisms to make blood sampling easier and less uncomfortable. These technologies are particularly suitable for remote clinical studies, longitudinal monitoring, home-based testing, and other applications where repeated visits to phlebotomy centers can create inconvenience. In February 2025, Tasso introduced its next-generation dried blood spot collection technology combining the Tasso Mini device with its Tile-T20 dried whole-blood cartridge. The system was developed to provide convenient and controlled blood sampling for applications including clinical trials and anti-doping testing. The transition toward simplified collection is changing how blood samples can be obtained outside conventional healthcare facilities. Manufacturers are increasingly focusing on ease of use, patient comfort, and standardized collection as important product differentiators.
02 Growing Development of Higher-Volume Capillary Collection Systems Capillary collection technologies are moving beyond traditional finger-stick devices that obtain only a few drops of blood. Manufacturers are developing systems capable of producing larger and more consistent capillary specimens, potentially widening the range of laboratory tests that can use minimally invasive samples.Larger specimens are particularly important when multiple analytes need to be measured or when laboratory procedures require more blood than conventional point-of-care tests. Improving blood flow and collection consistency can therefore extend capillary sampling into more sophisticated diagnostic applications. In 2026, Drawbridge Health's NanoDrop Lancet was highlighted among a new generation of upper-arm capillary sampling technologies. The device has an over-the-counter designation for obtaining capillary blood samples, supporting the movement toward accessible alternatives to conventional finger-stick and venous sampling. As higher-volume collection technologies mature, capillary sampling is expected to become increasingly relevant for applications extending beyond traditional glucose monitoring and basic rapid diagnostics.
01 Growing Need for Low-Volume Blood Sampling Among Pediatric and Geriatric Patients The increasing need for blood testing among newborns, children, older adults, and patients with difficult venous access is supporting capillary blood collection devices market demand. Conventional venipuncture can be difficult in patients with small, fragile, or difficult-to-locate veins, while repeated blood draws can create additional discomfort.Capillary sampling requires relatively small blood volumes and can simplify specimen collection for appropriate diagnostic tests. These advantages make lancets, microcollection tubes, and related products particularly relevant for neonatal screening, pediatric diagnostics, geriatric care, and patients requiring frequent monitoring.Growing requirements for safer and lower-volume blood sampling among vulnerable patient populations are directly increasing the clinical need for specialized capillary collection technologies.
01 Device Compatibility and Validation Requirements Can Restrict Clinical Adoption Capillary blood collection devices cannot always be used interchangeably across diagnostic systems. Differences in tube materials, anticoagulants, additives, specimen volumes, and handling procedures can influence laboratory results. Healthcare facilities may therefore need to perform additional validation before incorporating third-party collection devices into existing diagnostic workflows.These requirements can restrict the capillary blood collection devices market size by increasing validation costs, laboratory workload, and implementation complexity. Concerns about inaccurate results can also make laboratories more cautious when adopting alternative collection products.The development highlights the importance of demonstrating compatibility between collection devices, laboratory assays, and diagnostic platforms before broader clinical implementation.
01 Expansion of Capillary Specimens into Routine Clinical Chemistry Testing Advancements in specimen collection, serum separation, transportation, and sample stability are creating opportunities to use capillary specimens for laboratory tests traditionally dependent on venous blood.Companies developing collection systems that integrate with established laboratory workflows have opportunities to strengthen their capillary blood collection devices market share as minimally invasive sampling expands into clinical chemistry.
01 Maintaining Sample Quality and Pre-Analytical Consistency Maintaining reliable specimen quality remains an important challenge for the capillary blood collection devices industry. Small-volume samples can be affected by hemolysis, clotting, tissue-fluid contamination, inadequate filling, excessive squeezing during collection, and improper transportation. These factors can alter laboratory measurements and increase the risk of specimen rejection or repeat testing.The challenge becomes more important as capillary blood is introduced into increasingly complex diagnostic procedures. Collection systems must provide consistent specimens while minimizing variability associated with patient technique, operator handling, and transportation.Improving collection consistency, specimen stability, operator technique, and laboratory compatibility will remain critical for maintaining diagnostic accuracy as the clinical use of capillary specimens expands.
June 2026 BD (Becton, Dickinson and Company) expanded its blood collection portfolio with enhanced microcollection and capillary blood sampling solutions designed for pediatric, geriatric, and point-of-care testing applications. The product improvements focus on reducing sample volume requirements and improving patient comfort.
May 2026 Greiner Bio-One introduced upgraded MiniCollect® capillary blood collection systems featuring improved tube designs, enhanced sample handling, and optimized workflows for clinical laboratories and decentralized testing environments.
March 2026 SARSTEDT expanded its micro blood collection product portfolio with new capillary collection tubes and accessories designed for efficient sample transport, processing, and analysis in diagnostic laboratories.
October 2025 Terumo Corporation expanded its medical device portfolio with improved blood sampling technologies focused on safer, minimally invasive collection procedures and enhanced compatibility with modern diagnostic workflows.
August 2025 Haemonetics expanded its blood management solutions by strengthening its small-volume blood collection capabilities and digital monitoring technologies for clinical and diagnostic applications.